Results 201 to 210 of about 168,582 (331)

<div> Joint and Several liability for damages in the truck manufacturers cartel (en español "La responsabilidad solidaria por los daños del cártel de fabricantes de camiones")</div>

Francisco Marcos
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Protecting whose welfare? A document analysis of competition regulatory decisions in four jurisdictions across three harmful consumer product industries. [PDF]

Global Health
Wood B, Karouzakis C, Sievert K, Gallasch S, Sacks G.   +4 more
europepmc   +1 more source

Illicitly Manufactured Fentanyl Entering the United States. [PDF]

Cureus, 2021
Pergolizzi J, Magnusson P, LeQuang JAK, Breve F.   +3 more
europepmc   +1 more source

The dynamics of leniency application and the knock-on effect of cartel enforcement

, 2016
Jun Zhou
openalex   +1 more source

A prova no processo administrativo de investigação de cartel [PDF]

, 2015
Guilherme Favaro Corvo Ribas
openalex   +1 more source

Flagging cartel participants with deep learning based on convolutional neural networks

, 2023
Martin Huber, David Imhof
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Collusion risk in corporate networks. [PDF]

Sci Rep
Villamil I, Kertész J, Fazekas M.
europepmc   +1 more source

Modeling the role of police corruption in the reduction of organized crime: Mexico as a case study. [PDF]

Sci Rep, 2022
Aldana A, Larralde H, Aldana M.
europepmc   +1 more source